EICHORCondition: Locally Advanced or Metastatic Solid Tumors · Sponsor: Antengene Therapeutics Limited
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is a study of ATG-037 Monotherapy and Combination Therapy with Pembrolizumab in Patients with Locally Advanced or Metastatic Solid Tumors
This description comes directly from the study's public registry record.
Sunny He · 187 2152 1865 · sunny.he@antengene.com
Ting Liu · ting.liu@antengene.com
Always discuss trial participation with your own doctor first.
| Calvary Mater Newcastle | Sydney, New South Wales, Australia | Recruiting |
| Pindara Private Hospital | Benowa, Queensland, Australia | Recruiting |
| Southern Oncology Clinical Research Unit | Bedford Park, South Australia, Australia | Terminated |
| Peninsula & South Eastern Haematology and Oncology Group | Frankston, Victoria, Australia | Recruiting |
| One Clinical Research Pty Ltd | Mount Pleasant, Western Australia, Australia | Recruiting |
| Chongqing Cancer Hospital | Chongqing, Chongqing Municipality, China | Terminated |
| Guangdong Provincial People's Hospital | Guangzhou, Guangdong, China | Terminated |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05205109